Release Date: 10/05/16 09:21 Summary: Syntonic Presentation at 121 Tech Investment Hong Kong-PSF.AX Price Sensitive: No Download Document 1.73MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%